Back to News
Feb 24, 2026 12:00 PM

Respiree Strengthens Series A Syndicate to Advance Next-Generation Cardiorespiratory Care

HOUSTON and SINGAPORE, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced a new investment to expand its Series A syndicate.

New investor, One Six 8 Ventures, joins a seasoned investor syndicate led by We Venture Capital and ClavystBio, with participation from Adaptive Capital Partners, Greenwillow Capital Management and Seeds Capital. The Series A Round, announced in July 2025, supports expansion of Respiree's commercial team and U.S. presence, including company headquarters in Houston, Texas, at the Texas Medical Center (TMC) Innovation.

"We have been intentional in building a Series A syndicate that brings both strategic insight and regional expertise to solve critical health inefficiencies," said Dr. Gurpreet Singh, Founder and ...